GLP-1 and DPP-4 combination use is generally considered safe in terms of direct drug interactions, but the clinical benefit is questionable since both drugs ultimately increase GLP-1 activity
Furthermore, pouchees taking GLP-1 drugs took less antibiotics and less anti-diarrhoeal medication
Children: NAD+ supplements are generally not recommended for children due to a lack of safety data in humans 6
Baldessarini RJ, Tondo L, Vazquez GH
The flow-through, containing the cleaved core peptide, was collected, followed by buffer exchange using 7 mL of His6-tag buffer (20 mM Tris, 300 mM NaCl, pH 7.5)
Some patients could find that they notice weight loss within the first three months of starting semaglutide GLP-1 treatment, although the rate and extent of weight loss can vary based on factors like metabolism, diet, exercise routines, and overall health